- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
Patent holdings for IPC class A61K 39/395
Total number of patents in this class: 43942
10-year publication summary
|
2868
|
3060
|
3463
|
3388
|
3514
|
3730
|
3508
|
2953
|
2469
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 3864 |
855 |
| Regeneron Pharmaceuticals, Inc. | 3974 |
711 |
| Novartis AG | 11297 |
569 |
| Amgen Inc. | 3894 |
515 |
| F. Hoffmann-La Roche AG | 7942 |
476 |
| Chugai Seiyaku Kabushiki Kaisha | 1315 |
444 |
| The Regents of the University of California | 19479 |
439 |
| Janssen Biotech, Inc. | 1458 |
388 |
| Bristol-myers Squibb Company | 4886 |
378 |
| Hoffmann-La Roche Inc. | 3252 |
278 |
| Memorial Sloan-Kettering Cancer Center | 1883 |
278 |
| The Board of Trustees of the Leland Stanford Junior University | 6226 |
271 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
252 |
| Board of Regents, The University of Texas System | 5604 |
240 |
| The Johns Hopkins University | 5519 |
231 |
| Daiichi Sankyo Company, Limited | 1863 |
219 |
| Eli Lilly and Company | 3718 |
206 |
| Pfizer Inc. | 3373 |
202 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
202 |
| Takeda Pharmaceutical Company Limited | 2945 |
192 |
| Other owners | 36596 |